
Ifosfamide Shortage EU Expected to Persist Into 2027 Amid Supply Constraints
The Ifosfamide Shortage EU situation is set to continue well into the first quarter of next year, according to the European Medicines

The Ifosfamide Shortage EU situation is set to continue well into the first quarter of next year, according to the European Medicines

The Xpovio Myelofibrosis Trial has delivered mixed results, creating both optimism and uncertainty around the future of the therapy. Karyopharm Therapeutics announced that its

The Merck Terns Pharma Acquisition is emerging as one of the most closely watched deals in the pharmaceutical sector, with

The Indian Weight Loss Drug Regulation landscape is undergoing a significant shift as authorities move swiftly to curb the unauthorised sale and

The CVS Insulin Pricing Settlement marks a significant development in the ongoing scrutiny of pharmacy benefit managers and their role